Buthionine sulfoximine acts synergistically with doxorubicin as a sensitizer molecule on different tumor cell lines
{{output}}
The chemotherapeutic drug doxorubicin (DOX) has been widely used for treating solid tumors attributed to its antiproliferative effectiveness; however, its clinical use is limited due to side effects, including cardiotoxicity, myelosuppression, and drug resista... ...
